Biogen proposes to buy remaining stake in Sage in $442 million deal
(Reuters) - Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 ...
Read moreDetailsTag: Sage Therapeutics
Recent News
(Reuters) - Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 ...
Read moreDetails